| 发明名称 | Biomarkers for diagnosing ischemia | ||
| 摘要 | The present invention provides methods and compositions for diagnosing and predicting the occurrence of ischemia. For example, the present invention provides methods and compositions for diagnosing and predicting the risk and cause of transient neurological events (TNE) as ischemic or non-ischemic. | ||
| 申请公布号 | US9410204(B2) | 申请公布日期 | 2016.08.09 |
| 申请号 | US201314370709 | 申请日期 | 2013.01.04 |
| 申请人 | The Regents of the University of California | 发明人 | Sharp Frank;Jickling Glen C |
| 分类号 | C12Q1/68;G01N33/68 | 主分类号 | C12Q1/68 |
| 代理机构 | Weaver Austin Villeneuve & Sampson LLP | 代理人 | Weaver Austin Villeneuve & Sampson LLP |
| 主权项 | 1. A microarray attached to nucleic acids that hybridize to ischemia biomarkers comprising UBE2J1, ELAVL3, FCGR2B, BLVRA, JMJD6, DDAH2, PTRH2, CARD16, CAV1, ZNF608, NDUFB3, SLC22A4, PCMT1, CACNA1A, CASP1, LOC100129105, AK5, DIP2A, ETS1, CCND3, GNE, BCL9L, SPATA5 and LBH, wherein the microarray comprises 1000 or fewer hybridizing nucleic acids. | ||
| 地址 | Oakland CA US | ||